Evidence map›Paper›PMID 35954619›Full record

ArticleInternational journal of environmental research and public health2022

Needs of Lung Cancer Patients Receiving Immunotherapy and Acceptance of Digital and Sensor-Based Scenarios for Monitoring Symptoms at Home-A Qualitative-Explorative Study.

Milena von Kutzleben, Jan Christoph Galuska, Andreas Hein, Frank Griesinger, Lena Ansmann

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Milena von KutzlebenDivision for Organizational Health Services Research, School of Medicine and Health Sciences, Carl von Ossietzky University of Oldenburg, Ammerlaender Heerstr, 140, 26129 Oldenburg, Germany.
Jan Christoph GaluskaDivision for Organizational Health Services Research, School of Medicine and Health Sciences, Carl von Ossietzky University of Oldenburg, Ammerlaender Heerstr, 140, 26129 Oldenburg, Germany.
Andreas HeinDivision for Assistance Systems and Medical Technology, School of Medicine and Health Sciences, Carl von Ossietzky University of Oldenburg, Ammerlaender Heerstr, 140, 26129 Oldenburg, Germany.
Frank GriesingerDepartment of Hematology and Oncology at the Pius-Hospital Oldenburg, Georgstraße, University Department Internal Medicine-Oncology, 12, 26121 Oldenburg, Germany.
Lena AnsmannDivision for Organizational Health Services Research, School of Medicine and Health Sciences, Carl von Ossietzky University of Oldenburg, Ammerlaender Heerstr, 140, 26129 Oldenburg, Germany.ORCID 0000-0002-8628-7166

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe development of immunotherapy in the treatment for lung cancer has changed the outlook for both patients and health care practitioners. However, reporting and management of side effects are crucial to ensure effectiveness and safety of treatment. The aim of this study was to learn about the subjective experiences of patients with lung cancer receiving immunotherapy and to explore their potential acceptance of digital and sensor-based systems for monitoring treatment-related symptoms at home.

methodsA qualitative-explorative interview study with patients with lung cancer (

resultsParticipants had trouble to classify and differentiate between symptoms they experienced and it seemed challenging to assess whether symptoms are serious enough to be reported and to figure out the right time to report symptoms to health care practitioners. We identified four basic needs: (1) the need to be informed, (2) the need for a trustful relationship, (3) the need to be taken seriously, and (4) the need for needs-oriented treatment concepts. The idea of digital and sensor-based monitoring initially provoked rejection, but participants expressed more differentiated attitudes during the interviews, which could be integrated into a preliminary model to explain the acceptance of digital and sensor-based monitoring scenarios.

conclusionsSupporting lung cancer patients and their health care providers in communicating about treatment-related symptoms is important. Technology-based monitoring systems are considered to be potentially beneficial. However, in view of the many unfulfilled information needs and the unsatisfactory reporting of symptoms, it must be critically questioned what these systems can and should compensate for, and where the limits of such monitoring lie.

Indexed as

Delivery of Health CareLung NeoplasmsHumansImmunotherapyQualitative Researchadverse eventscontent analysisimmunotherapylung cancerpalliative carepatient’s needspreferencesqualitative research methodsside effectstechnology acceptance

Identifiers

PMID35954619
PMCPMC9368591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.